About
Medical Devices
Areas of Focus
Categories
Medical ImplantSan Diego & Southern California
Team (15)
Abraham Kometz
Abraham Kometz, M.D.
Endologix
team_member
Andrew Davis
Andrew DavisChief Commercial Officer
Endologix
team_member
Andrew ElBardissi
Andrew ElBardissi, M.D.
Endologix
team_member
Art Taylor
Member of the Board
Endologix
team_member
Bryan Sendrowski
Member of the Board
Endologix
team_member
Chip Richter
Chip RichterVice President, Health Economics and Reimbursement
Endologix
executive
Clinical Trials (26)
View allTotal Trials
26
As Lead Sponsor
24
As Collaborator
2
Total Enrollment
5,743
By Phase
NA: 20PHASE2: 1
By Status
COMPLETED: 16RECRUITING: 3ACTIVE_NOT_RECRUITING: 3UNKNOWN: 3WITHDRAWN: 1
Clinical Trials Pipeline26 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT05409118Lead Sponsor
JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization
NAWithdrawn
Started: Dec 31, 2025 · Completed: Dec 31, 2030
NCT06315023Lead Sponsor
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
N/ARecruiting
450 participants
Started: Oct 6, 2023 · Completed: Jun 7, 2032
NCT06990048Lead Sponsor
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
N/ARecruiting
2,000 participants
Started: Sep 21, 2023 · Completed: May 31, 2027
NCT05064540Lead Sponsor
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
NARecruiting
450 participants
Started: Sep 20, 2021 · Completed: Mar 31, 2031
NCT04625660Lead Sponsor
Detour2 Continued Access Study
NACompleted
11 participants
Started: Apr 7, 2021 · Completed: May 14, 2024
Locations (1)
Headquarters
Irvine, CA, United States
Map
Loading map...